Home · Stock · TWST

TWST Twist Bioscience Corp

Which ETFs hold TWST? Twist Bioscience Corp is held by 2 funds tracked by ETFpeek.

Held by 2 funds todayData as of 9 Oct 2026
HealthcareBiotechnology
$152.05
+387.5% 1y
$23.3052-week range$219.71
Market cap
$12.5B
3-month
+67.8%
CEO
Dr. Emily Marine Leproust Ph.D.
Revenue · last 4 qtrs (+23.2% YoY)

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc and Lilly TuneLab. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Provider

Currently Held By

ARK
ARKG
ARK Genomic Revolution ETF
Weight in fund8.55%
Shares held1,153,143
Market value$175.3M
View fund →
ARK
ARKK
ARK Innovation ETF
Weight in fund3.18%
Shares held1,437,776
Market value$218.6M
View fund →
Not held by the selected provider.
last 90 days
Net flow (90d):−$47.9M·3 BUY / 51 SELL·score ≥ 40
DatePersonActionPlanSharesValueScore i
2 Oct 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown45,736$8.6M90
2 Oct 2026
Adam Laponis
Chief Financial Officer
SELLUnknown8,057$1.5M90
2 Oct 2026
Paula Green
Senior Vice President of Human Resources
SELLUnknown10,088$1.9M90
2 Oct 2026
Patrick John Finn
President & COO
SELLUnknown25,714$4.9M90
2 Oct 2026
Dennis Cho
Chief Legal Officer & Corporate Secretary
SELLUnknown9,514$1.8M90
25 Aug 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown40,477
4 tranches
$6.1M90
21 Aug 2026
Patrick John Finn
President & COO
SELLUnknown4,046$563K80
21 Aug 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown6,639$923K80
12 Aug 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown19,952$2.5M90
10 Aug 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown113,318$14.2M90
7 Aug 2026
Robert Chess
Director / Other
SELLUnknown18,417$2.0M70
5 Aug 2026
Dennis Cho
Chief Legal Officer & Corporate Secretary
SELLUnknown14,205$1.6M90
Net flow (90d):−$47.9M·3 BUY / 51 SELL·showing all trades
DatePersonActionPlanSharesValueScore i
5 Oct 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown4,548
8 tranches
$919K30
2 Oct 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown45,736$8.6M90
2 Oct 2026
Adam Laponis
Chief Financial Officer
SELLUnknown8,057$1.5M90
2 Oct 2026
Paula Green
Senior Vice President of Human Resources
SELLUnknown10,088$1.9M90
2 Oct 2026
Patrick John Finn
President & COO
SELLUnknown25,714$4.9M90
2 Oct 2026
Dennis Cho
Chief Legal Officer & Corporate Secretary
SELLUnknown9,514$1.8M90
2 Oct 2026
Robert F. Werner
VP & Chief Accounting Officer
SELLUnknown1,482$280K30
1 Oct 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown655$131K30
24 Sep 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown5,203
10 tranches
$923K0
21 Sep 2026
Dennis Cho
Chief Legal Officer & Corporate Secretary
SELLUnknown348$58K30
21 Sep 2026
Paula Green
Senior Vice President of Human Resources
SELLUnknown294$49K30
21 Sep 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown1,687$279K30
25 Aug 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown41,570
5 tranches
$6.3M90
24 Aug 2026
Robert F. Werner
VP & Chief Accounting Officer
SELLUnknown854$120K30
21 Aug 2026
Patrick John Finn
President & COO
SELLUnknown4,046$563K80
21 Aug 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown6,639$923K80
21 Aug 2026
Dennis Cho
Chief Legal Officer & Corporate Secretary
SELLUnknown1,598$222K30
21 Aug 2026
Paula Green
Senior Vice President of Human Resources
SELLUnknown1,360$189K30
21 Aug 2026
Adam Laponis
Chief Financial Officer
SELLUnknown1,965$273K30
21 Aug 2026
Robert F. Werner
VP & Chief Accounting Officer
SELLUnknown669$93K30
12 Aug 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown19,952$2.5M90
12 Aug 2026
Katryn Blake
Director / Other
SELLUnknown2,240$275K30
12 Aug 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
BUYOption Exercise19,952$532K10
10 Aug 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown113,318$14.2M90
10 Aug 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
BUYOption Exercise113,318$3.0M20
7 Aug 2026
Robert Chess
Director / Other
SELLUnknown18,417$2.0M70
7 Aug 2026
Robert Chess
Director / Other
BUYOption Exercise18,417$219K0
5 Aug 2026
Dennis Cho
Chief Legal Officer & Corporate Secretary
SELLUnknown14,205$1.6M90
3 Aug 2026
Patrick John Finn
President & COO
SELLUnknown2,888$246K30
3 Aug 2026
Paula Green
Senior Vice President of Human Resources
SELLUnknown1,133$97K30
3 Aug 2026
Emily M. Leproust
Co-Founder, Board Chair & CEO
SELLUnknown5,101$435K30
3 Aug 2026
Robert F. Werner
VP & Chief Accounting Officer
SELLUnknown167$14K30
3 Aug 2026
Dennis Cho
Chief Legal Officer & Corporate Secretary
SELLUnknown1,070$91K30
23 Jul 2026
Patrick John Finn
President & COO
SELLUnknown2,238$210K30
Data: Finnhub (SEC Form 4 filings) · Score: ETFpeek heuristic
52 trades
DateFundDirectionShares Changed% Δ ETF i% Δ Position i
9 Oct 2026ARKKSELLReduced-78,125-0.27%5.15%
7 Oct 2026ARKKSELLReduced-13,597-0.75%0.66%
7 Oct 2026ARKGSELLReduced-7,277-1.17%0.61%
6 Oct 2026ARKKSELLReduced-47,949+0.13%2.30%
6 Oct 2026ARKGSELLReduced-42,775+0.00%3.43%
30 Sep 2026ARKKSELLReduced-46,971+0.02%2.55%
23 Sep 2026ARKGSELLReduced-21,336-0.36%1.69%
22 Sep 2026ARKGSELLReduced-12,537-0.23%1.00%
15 Sep 2026ARKKSELLReduced-15,138+0.15%0.94%
14 Sep 2026ARKKSELLReduced-46,018-0.10%2.79%
9 Sep 2026ARKKSELLReduced-13,257+0.07%0.79%
9 Sep 2026ARKGSELLReduced-23,805+0.11%1.87%
8 Sep 2026ARKKSELLReduced-12,298-0.10%0.73%
2 Sep 2026ARKKSELLReduced-46,772-0.18%2.79%
1 Sep 2026ARKGSELLReduced-26,111-0.27%1.98%
28 Aug 2026ARKGSELLReduced-15,729+0.04%1.17%
27 Aug 2026ARKKSELLReduced-97,328-0.06%5.45%
20 Aug 2026ARKKSELLReduced-75,436+0.43%3.93%
18 Aug 2026ARKKSELLReduced-21,268+0.13%1.09%
18 Aug 2026ARKGSELLReduced-42,028+0.04%3.29%
14 Aug 2026ARKKSELLReduced-11,552-0.08%0.59%
13 Aug 2026ARKKSELLReduced-40,822-0.06%2.04%
13 Aug 2026ARKGSELLReduced-7,026+0.08%0.55%
6 Aug 2026ARKKBUYAdded+20,966+0.57%1.03%
31 Jul 2026ARKKSELLReduced-13,459+0.06%0.66%
29 Jul 2026ARKKSELLReduced-39,588-0.17%1.93%
24 Jul 2026ARKKSELLReduced-45,712-0.04%2.17%
16 Jul 2026ARKKSELLReduced-59,600-0.08%2.62%
16 Jul 2026ARKGSELLReduced-11,611-0.08%0.88%
15 Jul 2026ARKKSELLReduced-22,892+0.06%0.99%
15 Jul 2026ARKGSELLReduced-12,414+0.03%0.93%
14 Jul 2026ARKKSELLReduced-39,296-0.11%1.63%
14 Jul 2026ARKGSELLReduced-16,880+0.03%1.25%
10 Jul 2026ARKKSELLReduced-37,906+0.06%1.54%
10 Jul 2026ARKGSELLReduced-60,891-0.15%4.30%
9 Jul 2026ARKKSELLReduced-11,990-0.03%0.50%
8 Jul 2026ARKGSELLReduced-9,230-0.60%0.64%
7 Jul 2026ARKGSELLReduced-31,093-0.23%2.12%
6 Jul 2026ARKKSELLReduced-29,615-0.14%1.21%
2 Jul 2026ARKGSELLReduced-34,123-0.38%2.34%
1 Jul 2026ARKKSELLReduced-154,084-0.26%6.03%
1 Jul 2026ARKGSELLReduced-8,568+0.08%0.57%
29 Jun 2026ARKGSELLReduced-19,391-0.14%1.28%
26 Jun 2026ARKGSELLReduced-37,566-0.05%2.42%
25 Jun 2026ARKGSELLReduced-29,686-0.15%1.95%
23 Jun 2026ARKGSELLReduced-20,284-0.26%1.31%
22 Jun 2026ARKGSELLReduced-78,084-0.39%4.81%
18 Jun 2026ARKGSELLReduced-80,139-0.87%4.72%
12 Jun 2026ARKKSELLReduced-415,959-0.12%10.80%
11 Jun 2026ARKKSELLReduced-24,021-0.03%0.73%
4 Jun 2026ARKKSELLReduced-96,133+0.08%2.95%
26 May 2026ARKKBUYAdded+105,810+0.18%3.42%
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

More stocks in these funds